We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Unveils $30B In Deals To Drive Strategic Overhaul

Law360, New York (April 22, 2014, 12:01 PM EDT) -- Novartis AG on Tuesday unveiled several transactions worth nearly $30 billion combined that will dramatically reshape its operations, including the $16 billion acquisition of rival GlaxoSmithKline PLC's cancer drugs, making it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.